Objective: The objective of the study was to determine whether early infratentorial and/or spinal cord lesions are long-term cumulative predictors of disability progression in multiple sclerosis (MS). Methods: We selected 153 MS patients from the longitudinal Amsterdam MS cohort. Lesion analysis was performed at baseline and year 2. Disability progression after 6 and 11 years was measured using the Expanded Disability Status Scale (EDSS) and EDSS-plus (including 25-foot walk and 9-hole peg test). Patients with spinal cord or infratentorial lesions were compared for the risk of 6- and 11-year disability progression to patients without spinal cord or infratentorial lesions, respectively. Subsequently, patients with lesions on both locations w...
Objective: To assess demographic, clinical, magnetic resonance imaging, and treatment exposure predi...
Objective: To investigate whether spinal cord (SC) lesion load, when quantified on axial images with...
The ability to reliably monitor disease progression in patients with multiple sclerosis (MS) is inte...
OBJECTIVE: The objective of the study was to determine whether early infratentorial and/or spinal co...
Background: Spinal cord pathology is an important substrate for long-term disability in multiple scl...
Spinal cord pathology is an important substrate for long-term disability in multiple sclerosis (MS)....
OBJECTIVE: To investigate the longitudinal spinal cord and brain changes in neuromyelitis optica (NM...
Objective To examine the temporal evolution of spinal cord (SC) atrophy in multiple sclerosis (MS), ...
Background and purpose: To assess the predictive value of T2 lesions on the rate of progression of d...
Background: Pathology in the spinal cord of patients with primary progressive multiple sclerosis (PP...
Objectives: To evaluate the combined contribution of brain and cervical cord damage in predicting 5-...
Prognostic markers of primary progressive multiple sclerosis evolution are needed. We investigated t...
Background and purpose: To predict disability and cognition in multiple sclerosis (MS) after 6 and 1...
Multiple sclerosis is a long-term disease that evolves over a period of 30 to 40 years with progress...
BACKGROUND: Spinal cord lesions in multiple sclerosis (MS) are an important contributor to disabilit...
Objective: To assess demographic, clinical, magnetic resonance imaging, and treatment exposure predi...
Objective: To investigate whether spinal cord (SC) lesion load, when quantified on axial images with...
The ability to reliably monitor disease progression in patients with multiple sclerosis (MS) is inte...
OBJECTIVE: The objective of the study was to determine whether early infratentorial and/or spinal co...
Background: Spinal cord pathology is an important substrate for long-term disability in multiple scl...
Spinal cord pathology is an important substrate for long-term disability in multiple sclerosis (MS)....
OBJECTIVE: To investigate the longitudinal spinal cord and brain changes in neuromyelitis optica (NM...
Objective To examine the temporal evolution of spinal cord (SC) atrophy in multiple sclerosis (MS), ...
Background and purpose: To assess the predictive value of T2 lesions on the rate of progression of d...
Background: Pathology in the spinal cord of patients with primary progressive multiple sclerosis (PP...
Objectives: To evaluate the combined contribution of brain and cervical cord damage in predicting 5-...
Prognostic markers of primary progressive multiple sclerosis evolution are needed. We investigated t...
Background and purpose: To predict disability and cognition in multiple sclerosis (MS) after 6 and 1...
Multiple sclerosis is a long-term disease that evolves over a period of 30 to 40 years with progress...
BACKGROUND: Spinal cord lesions in multiple sclerosis (MS) are an important contributor to disabilit...
Objective: To assess demographic, clinical, magnetic resonance imaging, and treatment exposure predi...
Objective: To investigate whether spinal cord (SC) lesion load, when quantified on axial images with...
The ability to reliably monitor disease progression in patients with multiple sclerosis (MS) is inte...